Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Charlotte › NPI 1467490102
Physician

Novant Health Medical Group, LLC

Novant Health Medical Group, LLC was paid $5.75M by Medicaid between Jan 2018 and Dec 2024, across 61 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 24% of everything it billed.

33Billing provider infoNOVANT HEALTH MEDICAL GROUP, LLC
CHARLOTTE, NC 28210
33aNPI1467490102assigned 06/03/2006
33bProvider typePediatrics Physician
28Total paid$5.75M
24GClaims266,027
24DCodes billed61
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in North Carolina

Rank by total paid#71 of 433
Median peer was paid$942K
This provider vs. median6.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201825,859$771K
201922,721$827K
202019,067$723K
202139,586$1.07M
202263,059$1.32M
202355,686$933K
2024incomplete40,049$108K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 24% 15,187 13,382 $1.40M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 21% 19,213 16,314 $1.22M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 8.4% 5,132 4,645 $481K
90460 Immunization administration through 18 years of age via any route, first or only component 8.2% 10,104 8,735 $474K
99199 Unlisted special service, procedure or report 6.7% 117,744 115,465 $387K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 6.6% 4,064 3,665 $380K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 6.6% 4,159 3,627 $379K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 3.9% 4,674 3,819 $227K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 2.7% 1,529 1,279 $155K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1.5% 4,905 4,046 $88K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.4% 1,252 1,063 $80K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1.4% 4,134 3,906 $78K
49 more codes
96110 Developmental screening, with scoring and documentation, per standardized instrument 1.3% 7,380 $75K
D0145 Oral evaluation for a patient under three years of age 1.1% 1,849 $63K
90472 Immunization administration, each additional vaccine (list separately) 1.0% 1,794 $60K
96127 <1% 10,347 $41K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,006 $30K
D1206 Topical application of fluoride varnish <1% 1,849 $28K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,379 $19K
99051 <1% 517 $13K
80061 Lipid panel <1% 768 $12K
90474 <1% 416 $8K
90651 <1% 403 $8K
90461 <1% 5,049 $7K
92552 <1% 8,987 $7K
0071A <1% 95 $5K
0072A <1% 84 $5K
85018 <1% 6,055 $4K
96160 <1% 1,017 $4K
90686 <1% 3,474 $3K
83655 <1% 420 $3K
96161 <1% 630 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 167 $2K
90734 <1% 193 $1K
99173 <1% 7,852 $1K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 39 $617.41
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 13 $578.89
87807 <1% 39 $548.14
90674 <1% 814 $449.95
87081 <1% 65 $440.82
81003 <1% 162 $280.25
90620 <1% 30 $193.05
91307 <1% 225 $105.38
92551 <1% 196 $74.30
36415 Collection of venous blood by venipuncture <1% 30 $66.98
90633 <1% 503 $65.74
90715 <1% 15 $44.55
36416 <1% 1,986 $32.20
99177 <1% 861 $29.26
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 39 $3.07
90670 0% 2,917 $0.00
90648 0% 575 $0.00
90685 0% 56 $0.00
90710 0% 25 $0.00
90700 0% 14 $0.00
90723 0% 352 $0.00
90680 0% 1,381 $0.00
90698 0% 1,276 $0.00
90744 0% 456 $0.00
99000 0% 93 $0.00
90696 0% 37 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWALTON, LEEA (RCS MANAGER)
Same official

Other billing entities under WALTON, LEEA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.